Immunic (IMUX)
Develops oral small-molecule candidates for multiple sclerosis and other inflammatory or autoimmune diseases.
$10.90
vs last close+0.07 (+0.65%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 61.85% | 8.44M shares | |
|---|---|---|---|
| 60 holders · as of Jun 30, 2026 | |||
| Insiders | 0.76% | 104.3K shares | |
| 7 holders · as of Jun 16, 2025 | |||
| Strategic holders | 8.48% | 1.16M shares | |
| 2 holders · as of May 6, 2026 | |||
| Other | 28.91% | 3.94M shares | |
| remainder | |||
13.64M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
13F, as of Jun 30, 2026
60 holders · 8.44M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Abrdn PLC | 824.4K | 6.04% | Jul 31, 2026 | |
| BVF Inc/IL | 765.3K | 5.61% | Aug 14, 2026 | |
| Millennium Management LLC | 740.3K | 5.43% | Aug 14, 2026 | |
| Avidity Partners Management LP | 669.9K | 4.91% | Aug 14, 2026 | |
| Braidwell LP | 645.0K | 4.73% | Aug 14, 2026 | |
| Laurion Capital Management LP | 610.3K | 4.47% | Aug 13, 2026 | |
| Vanguard Capital Management LLC | 571.6K | 4.19% | Aug 13, 2026 | |
| Jones Hill Capital LP | 539.8K | 3.96% | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 13G | Feb 20, 2026 | |
| Janus Henderson Group PLC | 9.99% | 13G | Dec 8, 2025 | |
| Adage Capital Management, L.P. | 9.99% | 13G | Aug 12, 2025 | |
| Avidity Partners Management LP | 9.90% | 13G | Apr 17, 2026 | |
| Commodore Capital LP | 9.90% | 13G | Feb 24, 2026 | |
| Trails Edge Capital Partners, LP | 8.70% | 13G | Feb 24, 2026 | |
| Deep Track Capital, LP | 8.69% | 13G | Mar 4, 2026 | |
| Nantahala Capital Management, LLC | 8.22% | 13G | Feb 13, 2026 | |
| Biotechnology Value Fund L P | 7.40% | 13D | Feb 20, 2026 | |
| Aberdeen Group plc | 6.85% | 13G | Feb 2, 2026 | |
| Laurion Capital Management LP | 6.06% | 839.5K | 13G | Aug 4, 2026 |
| 683 Capital Management, LLC | 5.90% | 13G | Feb 17, 2026 | |
| Soleus Capital Master Fund, L.P. | 5.50% | 13G | Feb 19, 2026 | |
| Integrated Core Strategies (US) LLC | 5.40% | 743.3K | 13G | May 6, 2026 |
| OrbiMed Advisors LLC | 5.30% | 756.9K | 13G | Aug 14, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.